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Summary
 
Plasmodium falciparum
 
 causes the most severe form of human malaria, which kills 
 
z
 
1.5–2.7 mil-
lion people every year, but the molecular mechanisms underlying the clinical symptoms and
the host–parasite interaction remain unclear. We show here that 
 
P
 
.
 
 falciparum
 
 produces prosta-
glandins (PGs) D
 
2
 
, E
 
2
 
, and F
 
2
 
a
 
. After incubation with 1 mM arachidonic acid (AA), cell homog-
enates of 
 
P
 
.
 
 falciparum
 
 produced PGs as determined by enzyme immunoassay and gas chroma-
tography–selected ion monitoring. PG production in the parasite homogenate was not affected
by the nonsteroidal antiinflammatory drugs aspirin and indomethacin, and was partially heat re-
sistant, whereas PG biosynthesis by mammalian cyclooxygenase was completely inhibited by
these chemicals and by heat treatment. Addition of AA to the parasite cell culture markedly in-
creased an ability of the parasite cell homogenate to produce PGs and of parasitized red blood
cells to accumulate PGs in the culture medium. PGD
 
2
 
 and PGE
 
2
 
 accumulated in the culture
medium at the stages of trophozoites and schizonts more actively than at the ring stage. These
findings are the first evidence of the direct involvement of a malaria parasite in the generation
of substances that are pyrogenic and injurious to the host defenses. We will discuss a possible
contribution of the parasite-produced PGs to pathogenesis and host-parasite interaction of 
 
P
 
.
 
falciparum
 
.
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alaria symptoms in an acute infection are general in-
flammatory responses, including periodic fever with
shivering, headache, body pains, sleepiness, and loss of ap-
petite, that are caused by the proliferating malaria parasite
cells at the erythrocytic stage. During acute blood stage
malaria, suppression of both T and B cell–mediated im-
mune responses is a common occurrence (1–3), although
the corresponding mechanism is not known, suggesting
that malaria parasites have certain strategies for evasion of
host defenses to establish the infection. Several papers have
reported enhancement of the TNF-
 
a
 
 level in malaria pa-
tient sera infected with 
 
Plasmodium
 
 
 
falciparum
 
 and 
 
Plasmo-
dium vivax
 
, suggesting that TNF-
 
a
 
 acts as an endogenous
pyrogenic substance (4–6).
Prostaglandins (PGs) are metabolites of arachidonic acid
(AA) via the cyclooxygenase pathway in mammals. They
play versatile biological roles in maintaining the homeosta-
sis of cell, tissue, and body. Among PGs, PGE
 
2
 
 is known to
be a pyrogenic substance (7) as well as an immunosuppres-
sor (8), and PGD
 
2
 
 is a somnogenic substance (9). They me-
diate inflammation and initiate physiological responses that
are similar to the symptoms observed during malaria.
For many years, it has been thought that malaria symp-
toms are mostly, if not solely, mediated by PGs produced
by host cells. We addressed the question whether or not 
 
P
 
.
 
falciparum
 
 produces PGs. Here we show the evidence that
 
P
 
.
 
 falciparum
 
 produces PGs in a way distinguishable from
the mammalian system.
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Materials and Methods
 
Culture and Preparation of Parasite Cells. P
 
.
 
 falciparum
 
 FCR3
and Honduras-1 strains were cultured as previously described (10)
and modified by Sugiyama et al. (11) in a 5% O
 
2
 
 and 5% CO
 
2
 
 at-
mosphere with 3% (vol/vol) of type O RBCs in complete me-
dium that consists of incomplete medium and 10% (vol/vol) heat
inactivated type O human serum; incomplete medium is RPMI
1640 supplemented with 25 mM Hepes, 25 mM NaHCO
 
3
 
, 0.36
mM hypoxanthine, 3.4 mM glutamine, 10 
 
m
 
g/ml gentamycin,
100 U/ml penicillin, and 100 
 
m
 
g/ml streptomycin. Type O
blood was freshly withdrawn into a tube containing citrate phos-
phate dextrose as anticoagulant. RBCs were washed three times
with incomplete medium and cells were collected by centrifuga-
tion at 3,000 rpm for 15 min. White blood cells were not de-
tected (
 
,
 
0.01%) in the prepared RBCs by visual microscopic in-
spection. The parasite cell culture was synchronized by sorbitol
treatment as previously described (11). Infected RBCs were iso-
lated by Percoll (Amersham Pharmacia Biotech Inc., Uppsala,
Sweden) density centrifugation as described by Tosta et al. (12)
with minor modifications. The cell suspension was overlaid on 3 vol
of 63% (vol/vol) Percoll in PBS. After centrifugation at 1,800 
 
g
 
for 10 min at 25
 
8
 
C, the interphase that contained mainly schiz-
onts and residual trophozoites was collected. The resulting cell
fraction was diluted with 2 vol of PBS and centrifuged. The para-
site cells were prepared by lysing the infected RBC membrane
with 0.075% saponin (11). The resulting parasite cell preparation
contained a small number of RBCs (0.5–0.9% of parasite cells),
but white blood cells were not detectable (
 
,
 
0.01%). Infected
RBCs and isolated parasite cells were suspended in 1.5 vol of PBS
and frozen before homogenate preparation.
 
Preparation and Incubation of Parasite Cell Homogenates.
 
A sus-
pension of 10
 
9
 
 parasite cells in 0.3 ml of PBS was mixed with 5.7
ml of 100 mM sodium phosphate, pH 7.0, containing a protease
inhibitor cocktail (Complete
 
Ô
 
; Boehringer Mannheim, Mann-
heim, Germany) and 600 mg of acid-washed glass beads (425–
600 
 
m
 
m; Sigma Chemical Co., St. Louis, MO) in a glass tube.
The content of the tube was vigorously vortexed for 2 min and
kept in an ice bath for 2 min. The cycle was repeated five times
to disrupt the cells. The resulting suspension was used as the cell
homogenates. The reaction mixture (500 
 
m
 
l) contained 100 mM
sodium phosphate (pH 7.0), 2 mM hematin, 5 mM tryptophan, 1
mM AA, and 300 
 
m
 
l of cell homogenates. The mixture was incu-
bated at 37
 
8
 
C for 30 min and the reaction was stopped by addi-
tion of 100 
 
m
 
l of 1 M HCl and 6 vol of cold ethyl acetate.
 
Extraction and Quantification of PGs.
 
3
 
H-PGD
 
2
 
, 
 
3
 
H-PGE
 
2
 
, and
 
3
 
H-PGF
 
2
 
a
 
 (60 Bq for each per assay; DuPont-NEN, Boston,
MA) were added to each sample as tracer to determine the recov-
ery of the following purification procedures. PGs produced in the
homogenates (300 
 
m
 
l) and those in the culture medium (8 ml)
were extracted three times with 6 vol of cold ethyl acetate and
separated by HPLC as previously described (13). PGD
 
2
 
, PGE
 
2
 
,
and PGF
 
2
 
a
 
 were quantified by enzyme immunoassay (EIA) by use
of the respective EIA kits (Cayman Chemical Co., Ann Arbor, MI).
 
Gas Chromatography Mass Spectrometry Analysis.
 
Gas chroma-
tography–selected ion monitoring (GC-SIM) analyses were run on
a double focusing mass spectrometer (M-80B; Hitachi, Tokyo,
Japan) equipped with a Van den Berg’s solventless injector and a
fused silica capillary column (Ultra#1; 25 m length, 0.32 mm inter-
nal diameter 280
 
8
 
C column temperature; Hewlett Packard, Palo
Alto, CA). The parasite cells and the culture medium were pre-
pared from the FCR3 strain grown in the medium containing 33
 
m
 
M AA. The synchronized 150-ml culture at trophozoite and
schizont stages was centrifuged at 1,800 
 
g
 
 for 5 min at room tem-
perature and washed with incomplete medium. Fresh complete
medium containing 33 
 
m
 
M AA was added to the culture. After
another 2-h incubation, the culture medium was taken and PGs
were extracted. Then PGs in culture medium and PGs produced in
the reaction by the parasite cell homogenates were fractionated by
HPLC. The PGs obtained in the eluate were converted into their
corresponding methyl ester–dimethylisopropylsilyl (ME-DMiPS)
ether or ME-methoxime (MO)-DMiPS ether derivatives accord-
ing to the method described previously, before applying on
GC-SIM (14).
 
Results
 
Cell homogenates of RBCs infected with the FCR3
(Gambia) strain of 
 
P
 
.
 
 falciparum
 
 and of the isolated parasite
cells by saponin treatment produced significant amounts of
PGD
 
2
 
, PGE
 
2
 
, and PGF
 
2
 
a
 
 after incubation with 1 mM AA at
37
 
8
 
C for 30 min (Fig. 1). PGD
 
2
 
 production in both homog-
enates is highest among three PGs. The amount of PGF
 
2
 
a
 
produced by homogenate of isolated parasite cells was sig-
nificantly more than that of infected RBCs. PG production
in the parasite homogenates required exogenous addition of
AA, i.e., no significant amounts of PGs were detected after
incubation without AA or without incubation (Fig. 1). PG
production was not observed in the homogenates of unin-
fected RBCs or with complete medium (Fig. 1).
To rule out the possibility that PG production is strain
specific, PG production was examined in two parasite
strains, FCR3 and Honduras-1. Fig. 2 
 
a
 
 shows PG produc-
tion was observed in both strains. In these parasite strains,
the effect of exogenous addition of AA into culture me-
dium was investigated. When parasite cells were grown in
the medium supplemented with 33 
 
m
 
M AA for 48 h before
harvest, PG production by the homogenates of FCR3 in-
creased from 200 to 700 pg/10
 
8
 
 cells for PGD
 
2
 
, and from
100 to 550 pg/10
 
8
 
 cells for PGF
 
2
 
a
 
 whereas PGE
 
2
 
 produc-
tion remained almost at the same level (120 pg/10
 
8
 
 cells)
(Fig. 2 
 
a
 
). The Honduras-1 cell homogenates also produced
PGD
 
2
 
 and PGF
 
2
 
a
 
 (120 and 80 pg/10
 
8
 
 cells, respectively),
and the PG production increased to 630 and 330 pg/10
 
8
 
cells, respectively, by adding 33 
 
m
 
M AA to the culture.
Accumulation of PGs in the culture medium of 
 
P
 
.
 
 falci-
parum
 
 was observed in both strains and this accumulation
was also increased by the addition of AA to culture me-
Figure 1. Production of PGs
by homogenates of uninfected
RBCs, infected RBCs, and para-
site cells. Parasite cells and in-
fected RBCs were isolated from
trophozoite- and schizont-rich
FCR3 cultures as described in
Materials and Methods. Unin-
fected RBCs were from the
same RBC source used for the
parasite cultures. Each cell ho-
mogenate was incubated at 378C for 30 min in the presence or absence of
1 mM AA. The amounts of PG produced by the cell homogenates were
measured by EIA and standardized to 1 ml of packed cell volume. White,
light gray, and dark gray bars represent PGD2, PGE2, and PGF2a, respec-
tively. 
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dium (Fig. 2 
 
b
 
). Culture supernatant of FCR3 and Hondu-
ras-1 strains cultured in the presence of 33 mM AA con-
tained PGD2 (670 and 500 pg/ml, respectively) in the
greatest amount, followed by PGE2 (370 and 330 pg/ml,
respectively), and PGF2a (50 and 100 pg/ml, respectively)
in lesser amounts. In the control reaction of uninfected
RBCs preincubated with 33 mM AA for 48 h, PGs were
not produced in the homogenates or in the medium (data
not shown). These results indicate that the capacity to pro-
duce PGs of parasite cell was increased by cultivation with
exogenous AA and that the produced PGs were accumu-
lated in the culture medium.
To examine the stage-specificity of PG production,
FCR3 strain cells were tightly synchronized with a life span
of 4–6 h and the amounts of PG in culture medium were
measured along with its development. Fig. 3 clearly shows
that PGs accumulated in the medium at trophozoite and
schizont stages more actively than at the ring stage.
The molecular identity of parasite-produced PGs was
supported by observations that each PG eluted at the same
position as that of its authentic counterpart in HPLC used
for purification of PGs before quantification by EIA and
GC mass spectrometry (MS). In addition, parasite-pro-
duced PGs showed the exactly proportional titration curves
in EIA to those of authentic PGs (data not shown). The
molecular identities of PGs produced by the parasite were
further confirmed by GC-SIM analysis. Analyses based on
the use of SIM and the DMiPS ether derivatives revealed
that all of the materials eluted from the HPLC had exactly
the expected molecular masses (m/z 668 for PGF2a and 595
for PGD2 and PGE2) and their characteristic fragment ions
(m/z 564, [M-31]1; 552, [M-43]1; and 524, [M-71]1 for
PGD2 and PGE2; and m/z 625, [M-43]1; 597, [M-71]1;
and 550, [M-118(DMiPSOH)]1 for PGF2a). Relative ion
intensity ratios of individual derivatives of PGs in the eluate
were identical to those of authentic standards. Fig. 4 shows
representative selected ion recordings for the ME-MO-
DMiPS ether derivatives of parasite-derived PGE2 com-
pared with those of authentic PGE2. Taken together, we
concluded that molecular structures of parasite-produced
PGs were identical to those of authentic PGs.
To exclude the possibility of contamination with mam-
malian cyclooxygenase, characteristics of the catalyst for
production of PGs in the parasite were examined. Table 1
shows that the activity from parasite cells was only partially
inhibited by treatment at 1008C for 10 min, and it was
completely abolished by heating at 1218C for 90 min. Fur-
thermore, PG production by parasite cell homogenates was
not affected by 3 mM of aspirin or 42 mM of indometha-
cin. In contrast, PG production catalyzed by the cyclooxy-
genase preparation from sheep seminal vesicle was com-
pletely abolished by heat treatment (at 1008C for 10 min)
Figure 2. Effect of AA addition on the production of PG by P. falci-
parum strains. (a) PG production by cell homogenates. P. falciparum FCR3
and Honduras-1 strains were grown in medium with or without the addi-
tion of 33 mM AA for 48 h before harvesting. After incubation of the par-
asite homogenates with 1 mM AA at 378C for 30 min, PGs produced
were measured by EIA. The values shown are from three independent
experiments with SE. In a typical experiment, FCR3 culture contained 0,
2.5, and 2.5% of RBCs infected with rings, trophozoites, and schizonts,
respectively, and that of Honduras-1 contained 0.8, 3.3, and 1.4% of
RBCs with rings, trophozoites, and schizonts, respectively. White, light
gray, and dark gray bars represent PGD2, PGE2, and PGF2a, respectively.
(b) PG release into the culture medium. FCR3 and Honduras-1 strain
cultures initially contained 0.3% of RBCs infected with trophozoites and
were cultivated for 48 h in medium (10 ml) with or without 33 mM AA.
After 48 h, 0.06, 1.25, and 0.53% of RBCs in the FCR3 culture and 0,
1.1, and 0.1% of RBCs in the Honduras-1 culture were infected with
rings, trophozoites, and schizonts, respectively. Cells were collected by
centrifugation at 1,800 g for 5 min and washed twice with incomplete
medium. Fresh medium containing 33 mM AA was added to the culture,
and the parasite cells were incubated for another 2 h. The culture super-
natant (8 ml) was then taken and centrifuged at 5,000 g for 30 min at 48C
to remove residual cells. The culture supernatants obtained were assayed
for PGs by EIA.
Figure 3. Time course of PG
release from parasite cells. A
ring-rich parasite cell culture
(120 ml) of P. falciparum FCR3
strain was grown in complete
medium containing 33 mM AA
for 48 h. This culture was then
treated with sorbitol and incu-
bated for 30 h followed by a sec-
ond sorbitol treatment to obtain
synchronized early rings with a
life span of 4–6 h after invasion
of fresh RBCs. The synchro-
nized 120-ml culture, supple-
mented with additional AA, was
divided into 10 plastic plates.
The time course was started after
the last sorbitol treatment. The
culture in each plate was centri-
fuged at 1,800 g for 5 min at
room temperature at the indi-
cated times and washed twice
with incomplete medium. Fresh
complete medium containing 33
mM AA was added to the cul-
ture, and the cultivation was
continued for another 2 h. The
culture supernatant (8 ml) was
then collected by centrifugation at 5,000 g and stored at 2808C until PG
quantification by EIA was performed. The Giemsa-stained parasite cells
were counted microscopically. Open and filled circles and open squares
represent ring, trophozoite, and schizont, respectively. White, light gray,
and dark gray bars represent PGD2, PGE2, and PGF2a, respectively.1200 Production of Prostaglandins by P. falciparum
and by these chemicals (Table 1). These results indicate that
the catalytic substance(s) for PG production in P. falciparum
is clearly different from the well-known enzymes involved
in the mammalian arachidonate cascade system.
When homogenates of P. falciparum cultured with 33
mM AA were incubated with various concentrations of
AA, PG production increased in a concentration-depen-
dent manner (Fig. 5). However, the concentration-depen-
dent curves are kinetically distinctive among PGs. PGD2
production almost linearly increased to 700 pg/108 cells
with 1 mM AA, giving an apparent Km value for AA .1
mM, whereas PGE2 and PGF2a formation reached almost
the maximum at z0.25 mM AA (180 and 550 pg/108 cells,
respectively) and increased slightly with the higher concen-
trations, giving an apparent Km value for AA of z50 mM.
Since the Km values for AA of the human cyclooxygenase-1
and -2 are reportedly 5–6 mM (15, 16), the catalytic sub-
stance(s) for PG production in P. falciparum is clearly differ-
ent from the mammalian enzyme.
Discussion
We presented the evidence for the first time that P. falci-
parum produces PGD2, PGE2, and PGF2a in a way that is
clearly distinguishable from the PG biosynthesis by mam-
malian cyclooxygenase. We also certified the molecular
identity of P. falciparum produced PGs by GC-SIM. The
finding of the production of PGs in a protozoan would
shed light on the evolution of PGs and the possibility of
novel pathways for their metabolism.
Since the catalysis for PG production in the parasite cell
was partially heat stable, the catalytic mechanism may not
involve the enzymatic activity. However, it is important to
notice that the capacity of PG production was increased
several-fold after cultivating the parasites with exogenously
added AA (33 mM) in a concentration comparable to AA
in blood stream (10 mM). Almost all of the parasite-pro-
duced PGs accumulated in the culture medium but not in
the cell, because we could not detect PGs in the cell ho-
mogenate without incubation with exogenous AA. It was
reported that arachidonic acid content in phospholipids of
P. falciparum–infected RBC plasma membrane is much
lower than that of normal RBC (7.85 and 17.36%, respec-
Figure 4. Selected ion recordings of PGE2 produced by the parasite cell
homogenate. The HPLC-purified sample was dissolved in 15% EtOH
and acidified with distilled HCl to pH 3. The resulting solution was sub-
jected to Sep-Pak C18 cartridge (Waters Co., Milford, MA). The cartridge
was subsequently washed with 15% EtOH and n-hexane, and then PGE2
was eluted with AcOEt. The resulting extract was methylated with freshly
prepared ethereal diazomethane and then purified by means of silica gel
column chromatography. Purified ME of PGE2 was converted to its MO-
DMiPS ether derivative as previously described (14) and then subjected to
GC-MS. Selected ion recordings monitoring its characteristic ions for
PGE2,  m/z 595, m/z 564, m/z 552, and m/z 524 are shown. The number
indicates ion intensity for each peak. (A) Traces of the selected ion re-
cordings of the ME-MO-DMiPS ether derivative of authentic PGE2. (B)
Traces of the selected ion recordings of the ME-MO-DMiPS ether deriv-
ative of PGE2 produced in a reaction with parasite cell homogenate.
Table 1. Effects of Nonsteroidal Antiinflammatory Drugs and Heat on PG Production by P. falciparum FCR3
Enzyme source Treatment PGD2 PGE2 PGF2a (pg/assay)
P.f. None 454 105 328
P.f. Aspirin 420 92 292
P.f. Indomethacin 408 100 279
P.f. 1008C, 10 min 272 79 213
P.f. 1218C, 90 min, 1.1 atm ND ND ND
Sheep cox None 930 1150 180
Sheep cox Aspirin 48 53 12
Sheep cox Indomethacin 30 46 15
Sheep cox 1008C, 10 min ND ND ND
The parasite cells (P.f.) were prepared from P. falciparum FCR3 strain grown in a medium containing 33 mM AA as described in Materials and Meth-
ods. The cyclooxygenase preparation of sheep seminal vesicle (sheep cox) was obtained from Eldan-Tech Ltd. (Israel). The parasite homogenates (5 3
107 cells) and sheep cyclooxygenase (300 ng protein) were incubated at 378C for 30 min with 1 mM AA in the presence or absence of 3 mM aspirin
or 42 mM indomethacin. Heat treatment was carried out at 1008C for 10 min and 1218C for 90 min before incubation with 1 mM AA. The amounts
of PGs produced were measured by EIA. Detection limits were 25, 11, and 10 pg in each assay for PGD2, PGE2, and PGF2a, respectively. ND, not
detected.1201 Kubata et al. Brief Definitive Report
tively) (17). Since Plasmodium is incapable of de novo bio-
synthesis of fatty acids (18), P. falciparum directly or indi-
rectly uses an exogenous source of arachidonic acid.
The amount of PGF2a produced by parasite homoge-
nates was higher than that of PGE2. However, culture me-
dium of both strains contained low levels of PGF2a in com-
parison to those of PGE2. PGF2a might be degraded by
parasite cells because after incubation of 3H-PGs (PGD2,
PGE2, and PGF2a) with parasite cell homogenates, a recov-
ered amount of 3H-PGF2a was decreased and a peak of un-
identified degradation product was produced from only
3H-PGF2a (data not shown).
The concentration-dependent curves for AA of in vitro
reaction with P. falciparum homogenates showed that pro-
ductions of PGF2a and PGE2 were kinetically different
from that of PGD2. Two distinct pathways may be in-
volved in PG formation in P. falciparum homogenates, i.e.,
one produces PGF2a and PGE2; the other, PGD2. If any,
the Km values for AA (z50 mM and .1 mM, respectively)
were much higher than those of the mammalian cyclooxy-
genase-1 and -2 (5–6 mM) (15, 16). Another possibility is
that P. falciparum homogenates contain both production
and degradation systems for PGs. In this case, the genera-
tion system may produce mainly PGE2 and PGF2a, and
PGD2 only weakly, whereas PGE2 and PGF2a may be more
actively degenerated than PGD2. However, we could not
detect the degradation product of PGE2 by HPLC after in-
cubation of the homogenates with [3H]-PGE2 (data not
shown).
The malaria fever is coordinated with the schizont rup-
ture associated with increased TNF-a level in the blood
stream. It was shown that a glycosylphosphatidylinositol-
like substance from malaria parasites stimulates the host
TNF-a production (19). The malaria fever was, therefore,
supposed to be caused by TNF-a after the induction of
host PGE2 production. Our observation that parasite-pro-
duced PGs were accumulated in the culture medium at
trophozoite and schizont stages raises a possibility that para-
site-produced PGE2 and PGD2 directly contribute to fever
and sleepiness as well.
Why does P. falciparum produce PGs? The most intri-
guing possibility is that the parasite-produced PGs modulates
the host defense mechanism against malaria infection. For
instance, an increased level of TNF-a was reported to sup-
press the parasite growth in vivo (20, 21). Lowering the
host TNF-a production by parasite produced PGE2 would
be beneficial to the parasite, since PGE2 regulates the level
of TNF-a (22, 23). In the other parasitic organism, it was
reported that microfilariae of Brugia malayi, intravascular
nematode, generates and releases prostacyclin and PGE2
from arachidonic acid (24, 25). The reported PG synthesis
is sensitive to indomethacin, unlike P. falciparum. These
prostanoids may influence host immune and other cellular
responses to ease the parasitism of microfilariae.
Further investigation into the contribution of parasite-pro-
duced PGs and catalysts in the clinical manifestation of this
disease would provide a new means for controlling malaria.
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Figure 5. AA dependency of
PG formation in the cell homo-
genates of P. falciparum. P. falci-
parum FCR3 strain was grown in
medium with the addition of 33
mM AA for 48 h before harvest-
ing. The parasite homogenates
were incubated at 378C for 30
min with various concentrations
of AA added exogenously. The
amounts of PGs produced were quantified as described under Materials
and Methods. Triangles, circles, and squares represent PGD2, PGE2, and
PGF2a, respectively.
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